ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

PEN Penumbra Inc

206.15
0.45 (0.22%)
Apr 24 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 336,365
Bid Price
Ask Price
News -
Day High 209.005

Low
180.93

52 Week Range

High
348.67

Day Low 204.12
Company Name Stock Ticker Symbol Market Type
Penumbra Inc PEN NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
0.45 0.22% 206.15 20:00:00
Open Price Low Price High Price Close Price Prev Close
207.31 204.12 209.005 206.15 205.70
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
9,188 336,365 $ 206.13 $ 69,333,589 - 180.93 - 348.67
Last Trade Time Type Quantity Stock Price Currency
19:00:00 33,142 $ 206.15 USD

Penumbra (PEN) Options Flow Summary

Overall Flow

Bearish

Net Premium

-7M

Calls / Puts

50.00%

Buys / Sells

200.00%

OTM / ITM

50.00%

Sweeps Ratio

0.00%

Penumbra Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
7.98B 38.70M - 1.06B 90.95M 2.35 87.69
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Penumbra News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No PEN Message Board. Create One! See More Posts on PEN Message Board See More Message Board Posts

Historical PEN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week209.48211.40199.38204.45351,186-3.33-1.59%
1 Month222.97228.43199.38214.75307,500-16.82-7.54%
3 Months251.96277.34199.38234.40351,443-45.81-18.18%
6 Months206.78277.34180.93229.15369,196-0.63-0.30%
1 Year280.68348.67180.93256.15376,624-74.53-26.55%
3 Years299.68348.67114.865230.61309,659-93.53-31.21%
5 Years131.80348.67107.50210.07360,99174.3556.41%

Penumbra Description

Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are primarily sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurovascular business, the firm offers products for the neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. Penumbra generates the majority of its revenue in the United States.

Your Recent History

Delayed Upgrade Clock